Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDF
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. (2r)-2-amino-3-phenylpropyl Carbamate
2. (r)-2-amino-3-phenylpropylcarbamate Hydrochloride
3. Adx-n05
4. Benzenepropanol, Beta-amino-, Carbamate (ester), (betar)-
5. Jzp-110
6. Solriamfetol
7. Sunosi
1. Jzp-110 Hydrochloride
2. 178429-65-7
3. Solriamfetol (hydrochloride)
4. K7ro88sp7a
5. Solriamfetol Hydrochloride [usan]
6. Solriamfetol Hydrochloride (usan)
7. R-228060
8. Sunosi (tn)
9. Unii-k7ro88sp7a
10. Adx-n05 Hydrochloride
11. Ykp-10a Hydrochloride
12. Schembl8430382
13. Adx-n-05 Hydrochloride
14. Skl-n-05 Hydrochloride
15. Chembl4297212
16. Dtxsid101027927
17. R-228060 Hydrochloride
18. Hy-109043a
19. Solriamfetol Hydrochloride [mi]
20. Solriamfetol Hydrochloride [who-dd]
21. Cs-0112102
22. O-carbamoyl-(d)-phenylalaninol Hydrochloride
23. D11328
24. Solriamfetol Hydrochloride [orange Book]
25. (d)-o-carbamoylphenylalaninol Hydrochloride Salt
26. R228060;jzp-110;adx-n05;skl-n05;ykp-10
27. (2r)-2-amino-3-phenylpropyl Carbamate, Monohydrochloride
28. (betar)-beta-amino-benzenepropanol 1-carbamate Hydrochloride (1:1)
29. (r)-(+)-2-amino-1-carbamoyloxy-3-phenylpropane Hydrochloride
30. Benzenepropanol, .beta.-amino-, 1-carbamate, Hydrochloride (1:1), (.beta.r)-
31. 561069-23-6
Molecular Weight | 230.69 g/mol |
---|---|
Molecular Formula | C10H15ClN2O2 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 5 |
Exact Mass | 230.0822054 g/mol |
Monoisotopic Mass | 230.0822054 g/mol |
Topological Polar Surface Area | 78.3 Ų |
Heavy Atom Count | 15 |
Formal Charge | 0 |
Complexity | 179 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Sunosi is indicated to improve wakefulness and reduce excessive daytime sleepiness in adult patients with narcolepsy (with or without cataplexy).
Sunosi is indicated to improve wakefulness and reduce excessive daytime sleepiness (EDS) in adult patients with obstructive sleep apnoea (OSA) whose EDS has not been satisfactorily treated by primary OSA therapy, such as continuous positive airway pressure (CPAP).
N06BA14
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A Solriamfetol Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Solriamfetol Hydrochloride, including repackagers and relabelers. The FDA regulates Solriamfetol Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Solriamfetol Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Solriamfetol Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Solriamfetol Hydrochloride supplier is an individual or a company that provides Solriamfetol Hydrochloride active pharmaceutical ingredient (API) or Solriamfetol Hydrochloride finished formulations upon request. The Solriamfetol Hydrochloride suppliers may include Solriamfetol Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Solriamfetol Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Solriamfetol Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Solriamfetol Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Solriamfetol Hydrochloride DMFs exist exist since differing nations have different regulations, such as Solriamfetol Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Solriamfetol Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Solriamfetol Hydrochloride USDMF includes data on Solriamfetol Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Solriamfetol Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Solriamfetol Hydrochloride suppliers with USDMF on PharmaCompass.
A Solriamfetol Hydrochloride written confirmation (Solriamfetol Hydrochloride WC) is an official document issued by a regulatory agency to a Solriamfetol Hydrochloride manufacturer, verifying that the manufacturing facility of a Solriamfetol Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Solriamfetol Hydrochloride APIs or Solriamfetol Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Solriamfetol Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Solriamfetol Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Solriamfetol Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Solriamfetol Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Solriamfetol Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Solriamfetol Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Solriamfetol Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Solriamfetol Hydrochloride suppliers with NDC on PharmaCompass.
Solriamfetol Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Solriamfetol Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Solriamfetol Hydrochloride GMP manufacturer or Solriamfetol Hydrochloride GMP API supplier for your needs.
A Solriamfetol Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Solriamfetol Hydrochloride's compliance with Solriamfetol Hydrochloride specifications and serves as a tool for batch-level quality control.
Solriamfetol Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Solriamfetol Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Solriamfetol Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Solriamfetol Hydrochloride EP), Solriamfetol Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Solriamfetol Hydrochloride USP).
LOOKING FOR A SUPPLIER?